The current PE ratio for National Healthcare stock as of Jul 13, 2026 is 26.05. This is calculated based on the TTM EPS of $7.98 and the stock price of $207.87 per share. The PE ratio has grown by 45% from its last 4 quarters average of 18.0.
The average historical PE ratio of National Healthcare for the last ten years is 21.35. The current P/E ratio of 26.05 is 22% higher than the historical average. Looking back at the last ten years, NHC's PE ratio peaked in the Mar 2020 quarter at 54.76, when the price was $71.73 and the EPS was $1.31. The lowest point was in the Jun 2021 quarter, when it reached 6.44 with a price of $69.9 and an EPS of $10.86.
Maximum annual increase: 441.89% in 2022
Maximum annual decrease: -68.98% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 17.67 | 8.74% | $137.09 | $7.76 |
| 2024 | 16.25 | -23.35% | $107.56 | $6.62 |
| 2023 | 21.2 | -47.98% | $92.42 | $4.36 |
| 2022 | 40.75 | 441.89% | $59.5 | $1.46 |
| 2021 | 7.52 | -68.98% | $67.94 | $9.03 |
| 2020 | 24.24 | 25.34% | $66.41 | $2.74 |
| 2019 | 19.34 | -4.59% | $86.43 | $4.47 |
| 2018 | 20.27 | 23.07% | $78.45 | $3.87 |
| 2017 | 16.47 | -27.41% | $60.94 | $3.7 |
| 2016 | 22.69 | 22.85% | $75.79 | $3.34 |
| 2015 | 18.47 | -4.79% | $61.7 | $3.34 |
| 2014 | 19.4 | 45.76% | $62.84 | $3.24 |
| 2013 | 13.31 | 3.34% | $53.91 | $4.05 |
| 2012 | 12.88 | 25.78% | $47.02 | $3.65 |
| 2011 | 10.24 | -28.74% | $41.9 | $4.09 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 20.01 | 13.24% | $159.7 | $7.98 |
| Dec 2025 | 17.67 | -4.9% | $137.09 | $7.76 |
| Sep 2025 | 18.58 | 17.89% | $121.51 | $6.54 |
| Jun 2025 | 15.76 | 18.85% | $107.01 | $6.79 |
| Mar 2025 | 13.26 | -18.4% | $92.8 | $7 |
| Dec 2024 | 16.25 | 4.37% | $107.56 | $6.62 |
| Sep 2024 | 15.57 | -14.12% | $125.77 | $8.08 |
| Jun 2024 | 18.13 | 1.68% | $108.4 | $5.98 |
| Mar 2024 | 17.83 | -15.9% | $94.51 | $5.3 |
| Dec 2023 | 21.2 | -3.24% | $92.42 | $4.36 |
| Sep 2023 | 21.91 | -26.28% | $63.98 | $2.92 |
| Jun 2023 | 29.72 | -37.05% | $61.82 | $2.08 |
| Mar 2023 | 47.21 | 15.85% | $58.07 | $1.23 |
| Dec 2022 | 40.75 | 33.17% | $59.5 | $1.46 |
| Sep 2022 | 30.6 | -12.02% | $63.34 | $2.07 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, NHC's PE ratio is higher than its 3, 5 and 10-year averages.
With a price to earnings (P/E) of 26.05, NHC ranks higher than the Healthcare sector and the industry average. But in comparison with the Healthcare sector average of 25.82, National Healthcare's price to earnings (P/E) is only 0.9% higher.
NHC's PE ratio stands lower than its peer stock ENSG, but it is higher than HCSG's and CYH's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CYH Community Health Systems Inc | 1 | $490.39M |
| HCSG Healthcare Services Group Inc | 25.04 | $1.65B |
| NHC National Healthcare Corp | 26.05 | $3.25B |
| ENSG Ensign Group Inc | 26.6 | $9.84B |
| EVH Evolent Health Inc | N/A | $665.89M |
NHC stock has a price to earnings ratio of 26.05 as of Jul 13, 2026.
The 3-year average price to earnings ratio for NHC stock is 17.83.
The 5-year average price to earnings ratio for NHC stock is 21.16.
Over the last ten years, the quarterly PE ratio reached its highest level at 54.76 in the Mar 2020 quarter.
The current PE ratio of NHC is 22% higher than the 10-year historical average.
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jul 13, 2026), National Healthcare's share price is $207.87. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $7.98. Therefore, National Healthcare's PE ratio for today is 26.05. PE RATIO(26.05) = STOCK PRICE($207.87) / TTM EPS($7.98)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.